Application of fecal microbiota transplantation in the treatment of refractory enteric diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031502

Enrollment

Unknown

Registered

2020-04-02

Start date

2020-04-02

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteric diseases

Interventions

Group UC:FMT

Group CC:FMT

Group IBS:FMT

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-70 years old; 2.Patients meet the diagnostic criteria of UC(ulcerative colitis),chronic constipation and irritable bowel syndrome; 3.All people in both groups voluntarily joined this study with informed consents.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Accompanied with severe primary diseases such as active malignant tumor, stroke, myocardial infarction and so on; 3.Patients with a history of abdominal surgeries; 4.Patients with a history of mental illness; 5.Patients requiring long-term use of immunosuppressive agents or antibiotics, including a history of taking antibiotics 1 month before enrollment.

Design outcomes

Primary

Measure	Time frame
Blood inflammatory index;Fecal bacteria;	—

Countries

China

Contacts

Public ContactTian Li

Weihai Municipal Hospital

litian_55@163.com+86 13563103602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026